BioCrossroads Has Money For Life Science Startups

Do you have a great med tech idea and need someone to fund it?  Perhaps BioCrossroads can help you with your venture.

BioCrossroads Inc. has raised an $8.25 million seed fund in its second attempt to help fledgling life sciences companies grow to the point where they can attract venture capital or a corporate funder. The Indiana Seed Fund II LLC was kicked off in late 2010 when Eli Lilly and Co. agreed to invest. Also chipping in are Indianapolis-based health insurer WellPoint Inc., Indiana University’s Research Technology Corp., Purdue University, the University of Notre Dame, the Richard M. Fairbanks Foundation and BioCrossroads’ own for-profit arm.

“It takes a long, long time in many cases to get these companies where they need to go,” says BioCrossroads President and Chief Executive Officer David Johnson. “This fund is designed to coax researchers who have always wanted to do this, to think big, to take a big risk and know there are going to be other people there to meet them halfway and invest in the company they’re trying to get started.”

“The market can be a very cruel place, and there are a lot of good ideas that wind up dying for lack of funding,” says Joe Hornett, leader of the Purdue Research Foundation (PRF), which funds the school’s research efforts,  ”I hope some of those good ideas that, otherwise, might wind up on the laboratory floor now make their way into the marketplace, and indeed, into the lives of consumers—particularly in the life sciences market, where health is improved and lives are saved. It’s absolutely critical.”

So, no more excuses.  If you have a great idea, there are people who are willing to help you make it a reality.

Bloomington- Who Knew?

Bloomington, Indiana, has one of the most significant clusters of medical-device and life-science companies in the nation. Bloomington is home to industry giants such as Cook Medical, the world’s largest privately held medical device maker, which specializes in minimally invasive surgical devices that allow doctors to operate on patients who are too high-risk for major surgery.

Also in Bloomington is the startup Morris Innovative, which has designed an FDA-approved medical device that uses a futuristic new bio-tissue (created by Cook Biotech) to help patients heal faster.

Other examples of innovation abound: Indiana University pediatric surgeon Mark Rodefeld has invented a tiny pump that keeps a newborn’s blood oxygenated while surgeons repair the heart of a child born with a single ventricle. Aeon Imaging has developed a laser-scanning digital camera that uses near infrared light to see past cataracts and detect underlying eye diseases.

 I live only 20 minutes from Bloomington, and have lived here for most of my life, and I am ashamed to admit, I had no idea.

September 23, 2011 – Indiana Life Sciences Collaboration Series

The Indiana Life Sciences Collaboration Series 2011 – 2012 schedule kicks off on September 23, 2011. This event: The “Consumerization” of Medical Product Marketing takes place at Indianapolis- IU School of Medicine, Walther Hall (Research Building III) Auditorium (980 W. Walnut Street, Indianapolis, IN).

Future events in this series are:

July 13, 2011 – IBJ Power Breakfast Series: Life Sciences

 

IBJ Presents Power Breakfast Series Life Science
JULY 13, 7:45AM
JW MARRIOTT, INDIANAPOLIS
INDIVIDUAL SEATING: $35.00
CORPORATE TABLE OF TEN: $700.00

*includes table signage and listing in event program
FEATURED PANELISTS TO INCLUDE
Richard Dimarchi
RICHARD D. DIMARCHI. PH.D.
Cox Professor of Biochemistry
Gill Chair in Biomolecular Sciences
Indiana University
David Johnson
DAVID JOHNSON
President and CEO
BioCrossroads
Oscar Moralez
OSCAR MORALEZ
Managing Partner
Stepstone Business Partners
Alan Rebar
ALAN REBAR, DVM, PH.D.
Senior Associate Vice President for
Research
Executive Director of Discovery Park
Purdue University
Q: What’s the pace of life science entrepreneurism in Indiana?
Q: How is Indiana poised to address the personalized medicine trend?
Q: What’s the outlook on seed and venture capital?
Q: What categories of work underway at university research parks could spur new commercial opportunities in the next few years?
Presenting Sponsor: Purdue Research Park Underwriting Sponsors: BioCrossroads, French Lick Resort, HardingPoorman, IHIF, Network Storage

 

 

Enhanced by Zemanta

February 25, 2011 – An Update on Regulatory Compliance

Dear Life Sciences Friend,

Just a reminder that the third Indiana Life Sciences Collaboration Conference in the series, An Update on Regulatory Compliance, isonly one month away! It will be held on Friday, February 25th in Indianapolis at Barnes & Thornburg LLP.  It is no secret that life sciences manufacturing companies are part a heavily regulated environment.  This conference brings experts from the device, pharma, biologics and nutrition sectors together with government and legal representatives to discuss the latest in approaches to distribute, market and sell their products.

I would like to extend a special “Thank You” to this conference’s  primary and supporting sponsors, Anson Group, Barnes & Thornburg LLP, Mead Johnson Nutrition and Beckman Coulter. I would also like to recognize brochure sponsors Cabello Associates and Miles Printing and this conference’s special marketing partner, BioCentury Publications.

The agenda for the day is  attached and is also available on the CBLS website at- http://kelley.iu.edu/CBLS/conferences/page19191.html

To register for the February conference or both of the remaining conferences in this year’s series, please go to- http://www.kelley.iu.edu/CBLS/conferences/registration/page16551.html

Enhanced by Zemanta

September 15, 2010 – 510(k) Reform: Using Recall Data to Analyze the 510(k) System

510(k) Reform – Using Recall Data to Analyze the 510(k) System

While much has been debated in the 510(k) realm, we have yet to see true statistical data – until now. Ralph Hall, counsel for Baker & Daniels, recently completed the first major study examining the 510(k) system. This presentation, which is sponsored by IHIF, IMDMC and Baker & Daniels LLP, will provide a detailed look into his research and the resulting potential implications for the 510(k) system.

The Institute of Medicine (IOM) is in the midst of an 18-month assessment of the 510(k) system and whether it provides adequate product safety. Hall’s work will be presented to the IOM and those Congressional offices interested in possible changes to the system. Hall’s study will provide the aforementioned policy makers with the critical data they need to make 510(k) guidance decisions.

Date: Wednesday, September 15, 2010

Time:
8:00 a.m. EDT I Registration
8:30 a.m. – 10:00 a.m. EDT I Programming

Location:
Indiana University Emerging Technologies Center (IUETC)
351 W. 10th Street
Indianapolis, IN 46202

Registration Fee: $25 for IHIF and IMDMC members, $75 for non-members

Please bring your check (payable to “IHIF”) to registration on the day of the presentation.

Register Here.

Enhanced by Zemanta

July 23, 2010 – Power Breakfast IBJ: Life Sciences

Power Breakfast IBJ: Life Sciences

July 23, 2010, 7:45AM
Marriott, Downtown

Individual Seating: $35
Corporate Table of Ten: $700

Featured Panelists include:

  • Anthony T. Armstrong, President & CEO of Indiana University Research and Technology Corp.
  • Andrew Cothrel, President & CEO, SONARMED, Inc.
  • Christofer Matney, Air Service Director, Indianapolis Airport Authority
  • Bart Peterson, Sr VP, Corporate Affairs and Communications, Eli Lilly

Learn more about the IBJ Power Breakfast.

Reblog this post [with Zemanta]

May 24, 2010 – FDA Issues: Making Good Drug and Device Investment Decisions

FDA Issues: Making Good Drug and Device Investment Decisions

Topics will include:

  • FDA & Regulatory Developments
  • Washington Update
  • Keeping Your Strategy Together & On Schedule
  • Finances: Successful Entry & Exit

Monday, May 24, 2010
Breakfast beginning at 7:00 a.m. EDT
Program from 7:30 a.m. – 9:00 a.m. EDT

Indiana University Emerging Technologies Center (IUETC)
351 West Tenth Street
Indianapolis, Indiana

RSVP by May 17, 2010 to Jana Langebartels at jana.langebartels@bakerd.com or 317-569-4614.

This program is presented free of charge, however you must RSVP in order to attend.

Reblog this post [with Zemanta]

CQ Has Roots in Bloomington Life Sciences

So maybe you read the articles in The Herald Times about Bloomington, IN tribulations with the life sciences industry. While our finger isn’t quite on Bloomington’s pulse, Creo Quality has been paying attention. Both Scott and I have roots and connections in the Bloomington area. I spent seven years of my career working for one of the large medical device companies in Bloomington. Scott now calls the area home.

The companies that are the pillars of Bloomington are in the life science industry. A generation ago, though, this was not the case. Large industrial manufacturing facilities employed thousands in this community. People from surrounding counties and towns flocked to Bloomington for decent, high paying jobs. Most of these companies have shut down their Bloomington operations, leaving the life sciences companies to save the day.

For some reason, the life sciences industry has curb appeal. I guess it relates to saving and improving quality of life. When talking about life sciences in Indiana, you have to discuss Bloomington–often times ahead of Indianapolis.

But now everyone wants the life sciences industry to stimulate the renaissance of Bloomington. For this to happen, industry needs to cooperate with research institutions (namely Indiana University), researchers need to cooperate with those in the civic space (local government), and the civic space needs to cooperate with industry.

There needs to be a sound strategy with implementation. This is tough to do because there are many people, organizations, companies, egos, etc. Everyone wants to get credit for something. To sum it up:

“We have been talking ‘high-tech’ in this community for 30 years,” Bill Cook is quoted as saying. “Not much has come of it. There is a lot of talk. I am not sure there are a whole lot of ideas.” (Quote from IBJ article “Trouble in life-sciences paradise”)

You can read other posts on the topic (Life Science Troubles… & A Few Simple Truths…), as well as subscribe to The Herald-Times to read the online versions of these stories.

Reblog this post [with Zemanta]

Life Sciences Troubles in Bloomington, IN

Bloomington, Indiana was at one point in time as talked about as Indianapolis, West Lafayette and Warsaw in the life sciences world. Now Bloomington is supposedly struggling to keep its edge, according to the The Herald-Times. Among the points made in the article are the fact that Bloomington has too few workers with too few qualifications.

“We have been talking ‘high-tech’ in this community for 30 years,” Cook is quoted as saying. “Not much has come of it. There is a lot of talk. I am not sure there are a whole lot of ideas.”

According to the IBJ, life sciences accounts for 6.8 percent of local jobs in the Bloomington area, but innovations coming out of Bloomington are few and far between.

Read the full article here.

Reblog this post [with Zemanta]

March 31, 2010 – Life Science Project Management Group General Mtg

Life Science Project Management Group March 2010 General Meeting

Date: Wednesday, March 31, 2010 from 7:00 PM – 9:00 PM (EST)

Location:

Kelley School of Business at IU
Room 3059 – Godfrey Graduate and Career Education Center
1309 E. 10th Street
Bloomington, IN 47405

10 Steps to Metrics that Matter
Reuben Vandeventer, Project Management Office, Baxter Biopharmaceutical Solutions

An interactive presentation and discussion on the common pitfalls of project, process and organizational metrics, and the steps that you can take to improve your metrics.

Success is something that we all strive for and we use many tools to achieve success, but none more over utilized than metrics – it’s all about metrics.  So the question must be posed: What are metrics?  Why do we want to know and see numbers, totals of numbers, averages of numbers and so on.  In this session, you will move through the progression of how to analyze your current state metrics, how to find weaknesses or flaws in those metrics and most importantly how to convert your metrics from lackluster to truly powerful. Design metrics that penetrate to the processes that matter by breaking down the 10 Steps to Metrics that Matter.

Can you attend?

Reblog this post [with Zemanta]

March 19, 2010 – INpact Meeting

Intellectual Property, Patents, and Trademarks

Speakers
Daniel L. Boots, Bingham McHale LLP
Brad Fravel, Indiana University Research & Technology Corporation (tentative)

There will be a speed networking session so be sure to bring plenty of business cards and short list of questions and/or needs!

Time: 11:00 a.m. – 1:00 p.m.
Location: Bingham McHale
10 W. Market St.
Suite 2700
Downtown Indianapolis

Cost: Non-members $20. Payment can be made at the meeting. Please make check payable to INpact.

Register here.

Reblog this post [with Zemanta]

February 26, 2010 – Effective Collaboration: A Study in Three Acts

The third conference Indiana Life Sciences Collaboration series for 2009/2010 is just a little over a month away – Friday, February 26th at Barnes & Thornburg in Indianapolis. The topic of this conference is Effective Collaboration: A Study in Three Acts. We are trying a new format for this conference – much of it will be  in the style of a theatrical production. The three acts deal with business challenges and partnering opportunities faced in the life sciences. The players are people drawn from industry (Barnes & Thornburg LLP, Eli Lilly and Company, IU Research Technology Corporation, ImmuneWorks, Kingsley Rose LLC, Volatus Advisors LLC, BioCrossroads, Covance Inc.) who have lived the situations portrayed.  Following the play will be a keynote presentation by Bart Peterson, Senior Vice President, Corporate Affair for Eli Lilly and Company, and the day will conclude with a panel discussing global partnering .

We thank our lead sponsors: Barnes & Thornburg LLP and Eli Lilly and Company for putting this event together.  This conference is helpful for those who deal with a broad range of issues including technical, legal, economic or cultural, that come into play when collaborating with other companies or organizations.

To view the complete program, directions,  and to register please visit the Center for the Business of Life Sciences website at – http://kelley.iu.edu/CBLS/conferences/page16784.html

For a registration shortcut, go to – http://kelley.iu.edu/CBLS/conferences/registration/page16551.html

Reblog this post [with Zemanta]

Indiana University Launches $10M Innovate Indiana Fund

Indiana University President McRobbie announced the new $10M Innovate Indiana Fund on Inside Indiana Business with Gerry Dick.

Mission of Innovate Indiana Fund

The Innovate Indiana Fund was established to invest in technologies discovered at Indiana University and help bring them to the marketplace. The Fund will assist with the translation of these technologies into innovative commercial products, services, and treatments, as well as with the setup of new technology–based companies to develop them.

McRobbie stated that $5M will be allocated to early stage seed funding and $5M will be allocated for companies seeking late stage investments.

Reblog this post [with Zemanta]

November 13, 2009 – Indiana Life Sciences Collaboration series

The second offering of the Indiana Life Sciences Collaboration series for 2009/2010 is just a month away – Friday, November 13th at Cook Medical’s world headquarters in Bloomington. The topic of this conference is Comparative Effectiveness: the Dollars and Sense.

We thank our lead sponsors: Cook Medical, Taft Stettinius & Hollister LLP, AIT Laboratories and the IU Johnson Center for Entrepreneurship & Innovation  for developing this great program.  This topic touches everyone in the life sciences value chain in a time when healthcare reform promises to bring more emphasis on consumer choice and empowerment. Recognition of the importance of this topic is found in the stimulus package that was enacted earlier this year which allocated $1.1 billion for Comparative Effectiveness research.

Keynote presentations:

  • Scott Gottlieb, M.D., Resident Fellow, American Enterprise Institute for Public Policy Research
  • Paul Keckley, Executive Director, Deloitte Center for Health Solutions
  • And other experts from the following key organizations: Cook Group, IU School of Medicine, Clarian Health, NoMoreClipboard, OrthoPediatrics, Eli Lilly and Company, Indiana Health Information Exchange, SIHO Insurance Services and more!

To view the complete program, directions,  and to register please visit the Center for the Business of Life Sciences website.

This series works because of the great support and efforts of all our sponsors. See a full listing of the many companies and organizations who help us bring these conferences to you at- http://kelley.iu.edu/CBLS/sponsors/conference/page16541.html

Reblog this post [with Zemanta]